首页> 外国专利> Domain CNAB SDRE STAPHYLOCOCCUS AUREUS and its use for vaccination

Domain CNAB SDRE STAPHYLOCOCCUS AUREUS and its use for vaccination

机译:CNAB SDRE STAPHYLOCOCCUS AUREUS域及其在疫苗接种中的用途

摘要

1. A polypeptide containing the CnaBE3 SdrE domain, where the polypeptide does not contain (1) a full-sized SdrE protein or (2) the amino acid sequence of formula 'B'.2. A polypeptide comprising a S.aureus SdrE protein fragment, wherein (a) the fragment comprises a CnaBE3 SdrE domain; (b) the polypeptide does not contain a full-sized SdrE protein; and (c) the polypeptide does not contain the amino acid sequence of formula 'B'.3. The polypeptide of claim 2, wherein the SdrE protein is 90% or more identical to SEQ ID NO: 3. The polypeptide according to any one of paragraphs. 1-3, where the CnaBE3 domain is at least 95% identical to SEQ ID NO: 8.5. The polypeptide according to any one of paragraphs. 1-3, containing SEQ ID NO: 8 or SEQ ID NO: 27.6. The polypeptide according to any one of paragraphs. 1-3, which, when administered to a human or mouse, causes the production of antibodies that recognize the epitope in SEQ ID NO: 8 or in SEQ ID NO: 27.7. The polypeptide according to any one of paragraphs. 1-3, having less than 500 amino acids. 8. A polypeptide containing a mutant domain of CnaBE3 SdrE S.aureus, where: - in one or more than one position of the amino acid, where the native domain of CnaBE3 SdrE S.aureus has an asparagine residue, the mutant has either (1) an amino acid deletion, or (2) amino acid substitution ; and / or - in one or more than one position of the amino acid, where the native CnaBE3 SdrE domain of S.aureus has an aspartate residue, the mutant has either (1) an amino acid deletion, or (2) amino acid substitution; and / or - in one or more than one amino acid position, where the native CnaBE3 SdrE domain of S.aureus has a lysine residue, does the mutant of (1) a deletion of amino acids, or (2) replace aminokisloty.9. The polypeptide according to claim 8, containing any of SEQ ID NO: 9-26.10. A polypeptide containing the S. aureus CnaB domain, wherein the CnaB domain includes an isopeptide bond. 11. The polypeptide of claim 10, wherein the S. aureus CnaB domain is derived from S. aureus SdrE. 12. The polypeptide of claim 11, wherein the S. aureus CnaB domain is a CnaBE3.13 domain. A polypeptide containing at least two CnaB domains, where: either (a) at least one of the CnaB domains is a CnaBE3 SdrE domain and at least one CnaB domain is not a CnaB SdrE domain; or (b) a polypeptide
机译:1.含有CnaBE3SdrE结构域的多肽,其中该多肽不包含(1)全尺寸的SdrE蛋白或(2)式'B'的氨基酸序列。包含金黄色葡萄球菌SdrE蛋白片段的多肽,其中(a)该片段包含CnaBE3 SdrE结构域; (b)该多肽不包含完整的SdrE蛋白; (c)该多肽不包含式'B'.3的氨基酸序列。 3.权利要求2的多肽,其中所述SdrE蛋白与SEQ ID NO:3具有90%或更高的同一性。 1-3,其中CnaBE3结构域与SEQ ID NO:8.5至少95%相同。根据段落中任一项的多肽。 1-3,包含SEQ ID NO:8或SEQ ID NO:27.6。根据段落中任一项的多肽。 1-3,当施用于人或小鼠时,其产生识别SEQ ID NO:8或SEQ ID NO:27.7中的表位的抗体。根据段落中任一项的多肽。 1-3,具有少于500个氨基酸。 8.含有CnaBE3 SdrE金黄色葡萄球菌突变域的多肽,其中:-在一个或多个氨基酸位置,其中CnaBE3 SdrE金黄色葡萄球菌的天然域具有天冬酰胺残基,该突变体具有( 1)氨基酸缺失,或(2)氨基酸取代;和/或-在金黄色葡萄球菌的天然CnaBE3 SdrE结构域具有天冬氨酸残基的氨基酸的一个或多个位置上,突变体具有(1)氨基酸缺失或(2)氨基酸取代;和/或-在一个或多个氨基酸位置,其中金黄色葡萄球菌的天然CnaBE3 SdrE结构域具有赖氨酸残基,突变体是否(1)缺失了氨基酸,或(2)取代了氨基酸。 。 9.根据权利要求8所述的多肽,其包含SEQ ID NO:9-26.10中的任一个。含有金黄色葡萄球菌CnaB结构域的多肽,其中所述CnaB结构域包括异肽键。 11.权利要求10的多肽,其中所述金黄色葡萄球菌CnaB结构域衍生自金黄色葡萄球菌SdrE。 12.权利要求11的多肽,其中所述金黄色葡萄球菌CnaB结构域是CnaBE3.13结构域。一种包含至少两个CnaB结构域的多肽,其中:(a)至少一个CnaB结构域是CnaBE3 SdrE结构域,至少一个CnaB结构域不是CnaB SdrE结构域;或(b)多肽

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号